MedTrace Logo

Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients

NCT00622934 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2010-11-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether Erythropoietin decrease stress responses and inflammation in trauma patient.

Conditions

  • Multiple Trauma

Interventions

DRUG

erythropoietin

300mg/kg erythropoietin 3 times on the first week of admission

DRUG

placebo

placebo

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • MOJTABA MOJTAHEDZADE · TUMS

  • MOSTAFA MOHAMMADY · TUMS

  • MOJTABA MOJTAHED · TUMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00622934 on ClinicalTrials.gov